Clinical Trials Directory

Trials / Completed

CompletedNCT03006536

Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Zealand University Hospital · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The proposed mechanism of action for LI-ESWT in ED is that it improves endothelial function and triggers angiogenesis through induction of local growth factors and endothelial nitric oxide synthase. The literature generally confirms that LI-ESWT is safe and cohort studies investigating the clinical effects have been encouraging. Meanwhile, randomized trials have shown contradictory results. Thus, a randomized trial in 67 PDE5-I responders showed statistically greater improvements in the Erectile Function Domain of the International Index of Erectile Function (IIEF) with active LI-ESWT treatment compared to a sham treatment (p=0.032).

Conditions

Interventions

TypeNameDescription
DEVICELi-ESWTParticipants will undergo 6 treatment sessions 2/week with 1 week pause with the Duolith® SD1 machine (Storz, Tägerwilen, Switzerland) according to the company's instructions

Timeline

Start date
2017-10-01
Primary completion
2022-03-13
Completion
2022-03-13
First posted
2016-12-30
Last updated
2024-01-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03006536. Inclusion in this directory is not an endorsement.